Sustained delivery of chABC improves functional recovery after a spine injury
- PMID: 36307768
- PMCID: PMC9615228
- DOI: 10.1186/s12868-022-00734-8
Sustained delivery of chABC improves functional recovery after a spine injury
Abstract
Introduction: Chondroitinase ABC (chABC) is an enzyme could improve regeneration and thereby improving functional recovery of spinal cord injury (SCI) in rodent models. Degradation of the active enzyme and diffusion away from the lesion are the causes of using hydrogels as a scaffold to deliver the chABC into the lesion site. In this meta-analysis, we investigated the effects of chABC embedded in a scaffold or hydrogel on the functional recovery after SCI.
Method: Databases were searched based on keywords related to chABC and spinal cord injury (SCI). Primary and secondary screening was performed to narrow down study objectives and inclusion criteria, and finally the data were included in the meta-analysis. The standard mean difference of the score of the functional recovery that measured by Basso, Beattie, Bresnahan (BBB) test after SCI was used to analyze the results of the reported studies. Subgroup analysis was performed based on SCI model, severity of SCI, transplantation type, and the follow-up time. Quality control of articles was also specified.
Results: The results showed that embedding chABC within the scaffold increased significantly the efficiency of functional recovery after SCI in animal models (SMD = 1.95; 95% CI 0.71-3.2; p = 0.002) in 9 studies. SCI model, severity of SCI, injury location, transplantation type, and the follow-up time did not affect the overall results and in all cases scaffold effect could not be ignored. However, due to the small number of studies, this result is not conclusive and more studies are needed.
Conclusion: The results could pave the way for the use of chABC embedded in the scaffold for the treatment of SCI and show that this method of administration is superior to chABC injection alone.
Keywords: Hydrogel; Scaffold; Spinal cord injury: animal model; chABC.
© 2022. The Author(s).
Conflict of interest statement
MRH states the possible conflicts of interest in Additional file. The other authors declare no conflict of interest.
Figures



Similar articles
-
The combined application of human adipose derived stem cells and Chondroitinase ABC in treatment of a spinal cord injury model.Neuropeptides. 2017 Feb;61:39-47. doi: 10.1016/j.npep.2016.07.004. Epub 2016 Jul 28. Neuropeptides. 2017. PMID: 27484347
-
Local Delivery of High-Dose Chondroitinase ABC in the Sub-Acute Stage Promotes Axonal Outgrowth and Functional Recovery after Complete Spinal Cord Transection.PLoS One. 2015 Sep 22;10(9):e0138705. doi: 10.1371/journal.pone.0138705. eCollection 2015. PLoS One. 2015. PMID: 26393921 Free PMC article.
-
[TRANSPLANTATION OF NEURAL STEM CELLS INDUCED BY ALL-TRANS- RETINOIC ACID COMBINED WITH GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR AND CHONDROITINASE ABC FOR REPAIRING SPINAL CORD INJURY OF RATS].Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2015 Aug;29(8):1009-15. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2015. PMID: 26677625 Chinese.
-
Chondroitinase ABC Administration in Locomotion Recovery After Spinal Cord Injury: A Systematic Review and Meta-analysis.Basic Clin Neurosci. 2022 Sep-Oct;13(5):609-624. doi: 10.32598/bcn.2021.1422.1. Epub 2022 Sep 1. Basic Clin Neurosci. 2022. PMID: 37313020 Free PMC article. Review.
-
Combination treatment with chondroitinase ABC in spinal cord injury--breaking the barrier.Neurosci Bull. 2013 Aug;29(4):477-83. doi: 10.1007/s12264-013-1359-2. Epub 2013 Jul 9. Neurosci Bull. 2013. PMID: 23839053 Free PMC article. Review.
Cited by
-
The Role of Exercise in the Alleviation of Neuropathic Pain Following Traumatic Spinal Cord Injuries: A Systematic Review and Meta-analysis.Neurospine. 2023 Sep;20(3):1073-1087. doi: 10.14245/ns.2346588.294. Epub 2023 Sep 30. Neurospine. 2023. PMID: 37798999 Free PMC article.
-
Scientific Advances in Neural Regeneration After Spinal Cord Injury.Cureus. 2025 Feb 6;17(2):e78630. doi: 10.7759/cureus.78630. eCollection 2025 Feb. Cureus. 2025. PMID: 40062077 Free PMC article. Review.
-
Chondroitinase ABC in spinal cord injury: advances in delivery strategies and therapeutic synergies.Front Bioeng Biotechnol. 2025 Jun 9;13:1604502. doi: 10.3389/fbioe.2025.1604502. eCollection 2025. Front Bioeng Biotechnol. 2025. PMID: 40552113 Free PMC article. Review.
-
Current Advancements in Spinal Cord Injury Research-Glial Scar Formation and Neural Regeneration.Cells. 2023 Mar 9;12(6):853. doi: 10.3390/cells12060853. Cells. 2023. PMID: 36980193 Free PMC article. Review.
-
In vitro assessment of protamine toxicity with neural cells, its therapeutic potential to counter chondroitin sulfate mediated neuron inhibition, and its effects on reactive astrocytes.Adv Ther (Weinh). 2024 Feb;7(2):2300242. doi: 10.1002/adtp.202300242. Epub 2024 Jan 10. Adv Ther (Weinh). 2024. PMID: 39071184 Free PMC article.
References
-
- Zeinali A, Mellat A, Rahimdel A, Alahsab A. A study on demographic pattern, causes and level of lesion in the spinal cord injured patients in Yazd City in 2009–2015. Int J Med Res Health Sci. 2016;5:447–451.
-
- Yousefifard M, Ramezani F, Vaccaro AR, Hosseini M, Rahimi-Movaghar V. The role of intraspinal administration of self-assembled peptide on locomotion recovery after spinal cord injury: a systematic review and meta-analysis study. Neuromodulation. 2022 doi: 10.1016/j.neurom.2022.01.011. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical